TNF Receptor-Associated Periodic Syndrome Latest Advances

Unmasking Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): diagnostic pitfalls of de novo mutations.

Journal: The journal of allergy and clinical immunology. In practice

Published: March 16, 2025

A rare case of uncharacterized autoinflammatory disease: Patient carrying variations in NLRP3 and TNFRSF1A genes.

Journal: American journal of medical genetics. Part A

Published: February 10, 2024

Tocilizumab for treating mevalonate kinase deficiency and TNF receptor-associated periodic syndrome: a case series and literature review.

Journal: Pediatric rheumatology online journal

Published: December 19, 2023

Efficacy of canakinumab for mosaic tumor necrosis factor receptor associated periodic syndrome.

Journal: European journal of internal medicine

Published: December 11, 2023

Clinical analysis of 10 cases of multi-center tumor necrosis factor receptor-associated periodic syndrome

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: November 29, 2023

The First Case of a Korean Patient with a Mutation-Confirmed Tumor Necrosis Factor Receptor-Associated Periodic Syndrome.

Journal: Yonsei medical journal

Published: September 11, 2023

Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study.

Journal: Pediatric rheumatology online journal

Published: March 16, 2023

Long-Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor-Associated Periodic Syndrome: Results From a Phase III Trial.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: January 19, 2023

Study of the ocular surface in tumor necrosis factor receptor-associated periodic syndrome (TRAPS): A case report and literature review.

Journal: Journal francais d'ophtalmologie

Published: September 13, 2022

TNFRSF1A-pR92Q variant identifies a subset of patients more similar to systemic undifferentiated recurrent fever than TNF receptor-associated periodic syndrome.

Journal: Clinical and experimental rheumatology

Published: June 16, 2022

TRAPS mutations in Tnfrsf1a decrease the responsiveness to TNFα via reduced cell surface expression of TNFR1.

Journal: Frontiers in immunology

Published: April 22, 2022

A rare onset in tumour necrosis factor receptor-associated periodic syndrome: recurrent macrophage activation syndrome triggered by COVID-19 infection.

Journal: Rheumatology (Oxford, England)

Published: April 22, 2022

Filters

Unmasking Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): diagnostic pitfalls of de novo mutations.

Unmasking Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): diagnostic pitfalls of de novo mutations.

A rare case of uncharacterized autoinflammatory disease: Patient carrying variations in NLRP3 and TNFRSF1A genes.

A rare case of uncharacterized autoinflammatory disease: Patient carrying variations in NLRP3 and TNFRSF1A genes.

Tocilizumab for treating mevalonate kinase deficiency and TNF receptor-associated periodic syndrome: a case series and literature review.

Tocilizumab for treating mevalonate kinase deficiency and TNF receptor-associated periodic syndrome: a case series and literature review.

Efficacy of canakinumab for mosaic tumor necrosis factor receptor associated periodic syndrome.

Efficacy of canakinumab for mosaic tumor necrosis factor receptor associated periodic syndrome.

Clinical analysis of 10 cases of multi-center tumor necrosis factor receptor-associated periodic syndrome

Clinical analysis of 10 cases of multi-center tumor necrosis factor receptor-associated periodic syndrome

The First Case of a Korean Patient with a Mutation-Confirmed Tumor Necrosis Factor Receptor-Associated Periodic Syndrome.

The First Case of a Korean Patient with a Mutation-Confirmed Tumor Necrosis Factor Receptor-Associated Periodic Syndrome.

Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study.

Efficacy and safety of thalidomide in children with monogenic autoinflammatory diseases: a single-center, real-world-evidence study.

Long-Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor-Associated Periodic Syndrome: Results From a Phase III Trial.

Long-Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor-Associated Periodic Syndrome: Results From a Phase III Trial.

Study of the ocular surface in tumor necrosis factor receptor-associated periodic syndrome (TRAPS): A case report and literature review.

Study of the ocular surface in tumor necrosis factor receptor-associated periodic syndrome (TRAPS): A case report and literature review.

TNFRSF1A-pR92Q variant identifies a subset of patients more similar to systemic undifferentiated recurrent fever than TNF receptor-associated periodic syndrome.

TNFRSF1A-pR92Q variant identifies a subset of patients more similar to systemic undifferentiated recurrent fever than TNF receptor-associated periodic syndrome.

TRAPS mutations in Tnfrsf1a decrease the responsiveness to TNFα via reduced cell surface expression of TNFR1.

TRAPS mutations in Tnfrsf1a decrease the responsiveness to TNFα via reduced cell surface expression of TNFR1.

A rare onset in tumour necrosis factor receptor-associated periodic syndrome: recurrent macrophage activation syndrome triggered by COVID-19 infection.

A rare onset in tumour necrosis factor receptor-associated periodic syndrome: recurrent macrophage activation syndrome triggered by COVID-19 infection.